SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-399619
Filing Date
2014-11-06
Accepted
2014-11-06 06:30:55
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d801018d10q.htm 10-Q 602933
2 EX-31.1 d801018dex311.htm EX-31.1 6813
3 EX-31.2 d801018dex312.htm EX-31.2 6816
4 EX-32.1 d801018dex321.htm EX-32.1 4337
5 EX-32.2 d801018dex322.htm EX-32.2 4334
  Complete submission text file 0001193125-14-399619.txt   5294202

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srpt-20140930.xml EX-101.INS 833499
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20140930.xsd EX-101.SCH 50275
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20140930_cal.xml EX-101.CAL 64025
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20140930_def.xml EX-101.DEF 146124
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20140930_lab.xml EX-101.LAB 382613
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20140930_pre.xml EX-101.PRE 280527
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 141198703
SIC: 2834 Pharmaceutical Preparations